Buy and build Investment group Tristone Capital, through its care division Tristone Healthcare, has acquired North Wales-based care business, ProCare (Wales) Limited.  

Liva Healthcare, a European market leader in scalable digital health coaching, has secured a new funding round of EUR 24.5 million, led by Verlinvest, the go-to investor for mission-driven entrepreneurs and category-defining global consumer brands. The investment will enable Liva to strengthen its position as a European leader in digital health and lifestyle coaching for chronic disease prevention and management.   

Peptone, the computational physics company, has built the world’s first protein engineering operating system and, thanks to $2.5 million seed round led by Hoxton Ventures and supported by dRx Capital, a venture arm of Novartis Pharma AG, Founders Factory and a number of angel investors including Brent Hoberman, the next-gen supercomputing company is now looking to further develop its groundbreaking technology in order to take on the high-value protein targets and reduce the risk of failure in early stages of drug development.

Angelini Pharma, an international pharmaceutical company which is a part of the private Italian Angelini Group – and Arvelle Therapeutics, a Swiss-based biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS disorders, has announced that they have concluded a definitive merger agreement under which Angelini Pharma will acquire Arvelle Therapeutics in an all cash transaction for a total aggregate valuation of up to $960 million. Following regulatory approval, $610M will be paid.  Subsequently, and subject to cenobamate reaching certain revenue targets, a further $350M will be paid.

The Zero Carbon Fund has made an investment in the pre-seed funding round of Phycobloom, a UK-based bio-technology company engineering algae that will enable cheap, carbon-neutral biofuels that can power future air travel and more.

OKKO Health, a digital eye care company, has received investment from seven Henley Business Angels (HBA) members, contributing towards a total funding round of £900,000. The amount invested by HBA members was £145k, making it the largest amount invested since HBA’s establishment in 2016.

Innovative Scottish-based drug delivery company, Bio-Images Drug Delivery Limited (BDD), has positioned itself for rapid growth with a further round of investment in its GMP* manufacturing capabilities alongside strategic recruitment to the senior leadership team and the Board of Directors.  The £1.2m investment, has been led by Edinburgh-based business angel investment syndicate, Archangels, supported by Scottish Enterprise and BioCity Investments. 

Alderley Park-based proteomic-data science and diagnostics company, Kinomica, has secured £3.9 million in funding for pioneering technology 

UK-based biotechnology company ILC Therapeutics has announced that it has secured significant investment from its first global investor Medical Incubator Japan. The Scottish life sciences company, which has received international attention through its work exploring COVID-19 therapeutic treatments with the University of St Andrews, is MIJ’s first investment in a biotech company in Europe. 

Research technology company uMed has raised £3.7m in venture capital from AlbionVC, Delin Ventures and Playfair Capital, along with Silicon Valley’s 11.2 Capital.

The latest round of funding¹ will see uMed give healthcare providers in the UK and US, including GPs and hospitals, the tools to run patient research more efficiently while safeguarding patient data and ensuring regulatory compliance.

Navenio, the UK healthcare scale-up, has announced a $1.1 million investment from Future Planet Capital to help revolutionise healthcare efficiency worldwide.

The Navenio solution, a spin-out of Oxford University, provides infrastructure-free indoor location solutions, the equivalent of GPS for use indoors, to power a range of apps and platforms in sectors including healthcare. Navenio is tackling the rising cost of healthcare with a tool that can increase workplace productivity by up to 100%, freeing up clinical resources for other high value tasks.

The pan-European private equity firm Silverfleet Capital has agreed to sell its majority stake in 7days, a German supplier of workwear for the healthcare industry, to a consortium of private equity firms, Chequers Capital and Paragon Partners, generating a 3.1x gross money multiple. Completion of the transaction is subject to regulatory approval and is expected by January 2021.